Bulent Aydogan to Multiple Myeloma
This is a "connection" page, showing publications Bulent Aydogan has written about Multiple Myeloma.
Connection Strength
0.190
-
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200?mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma. Leuk Lymphoma. 2018 07; 59(7):1666-1671.
Score: 0.117
-
Linear accelerator-based intensity-modulated total marrow irradiation technique for treatment of hematologic malignancies: a dosimetric feasibility study. Int J Radiat Oncol Biol Phys. 2011 Mar 15; 79(4):1256-65.
Score: 0.072